📊 MasTec, Inc. (MTZ) — Technische & Fundamentele Analyse
​Koers: $290.38
Trend: Bullish
Momentum: Licht positief
Risico-score: 6/10

🔥 Trendanalyse

• Nieuwe 52-week high rond $300 → bevestigt sterke uptrend
• Intraday low op $276 → hoge volatiliteit, maar kopers blijven dominant
• Structuur: hogere highs & hogere lows
• Trend is krachtig, maar kortetermijn overextended

➡️ Conclusie technisch: Primary trend = UP

💰 Fundamentele Analyse

• P/E: 69 → relatief duur gewaardeerd
• Market cap: ~$22.9B
• Actief in infrastructuur & energieprojecten (AI-datacenters, power, telecom)
• Structurele groei door Amerikaanse infrastructuurinvesteringen

Ondanks de hoge waardering rechtvaardigt de groeiverwachting deels de premium multiple.

📈 Sentiment & Catalysts

• Positief sectorsentiment (infrastructuur & energie)
• Earnings beat zonder grote gap → gezonde, gecontroleerde stijging
• Geen recente upgrades nodig: momentum komt uit prijsactie

⚖️ Risico

• Hoge waardering → gevoelig voor correcties
• Volatiliteit rond highs
• Marktbreed sentiment blijft bepalend

Risk/Reward blijft aantrekkelijk zolang $270 standhoudt.

🟢 BUY SETUP🎯 StrategiePrimary entry (agressief):
Break & hold boven $300 → momentum continuation trade
Preferred entry (slim geld):
Buy the dip in zone $270 – $280
🛑 Stop-lossOnder $260 (trendbreuk)
🎯 Targets

• $315 (korte termijn momentum target)
• $335–350 (swing target bij voortzetting trend)

📊 EindconclusieTrend is duidelijk bullish.
Fundamenteel duur, maar groei en sector-momentum ondersteunen de waardering.
🔔 Advies:BUY op dip richting $270–280
Momentum traders kunnen kopen bij doorbraak boven $300.
Wil je dat ik hier ook een TradingView-stijl technische onderbouwing (MA, RSI, volume analyse) aan toevoeg zoals je vaak gebruikt voor je X-account?

graag in het engels📊 MasTec, Inc. (MTZ) — Technical & Fundamental AnalysisPrice: $290.38
Trend: Bullish
Momentum: Slightly positive
Risk Score: 6/10

🔥 Trend Analysis

• New 52-week high near $300 → confirms strong uptrend
• Intraday low at $276 → high volatility, but buyers remain in control
• Clear structure of higher highs and higher lows
• Short-term slightly overextended, but trend remains intact

➡️ Technical conclusion: Primary trend = UP

💰 Fundamental Strength

• P/E ratio: 69 → Expensive valuation
• Market cap: ~$22.9B
• Strong positioning in infrastructure, energy, telecom, and AI-related power projects
• Structural growth supported by U.S. infrastructure investments

While valuation is premium, growth outlook justifies part of the multiple.

📈 Sentiment & Catalysts

• Positive sector momentum (infrastructure & energy)
• Earnings beat without a major gap → healthy, controlled price action
• Momentum driven by price strength rather than analyst upgrades

⚖️ Risk Assessment

• High valuation → sensitive to pullbacks
• Elevated volatility near highs
• Broader market sentiment remains a key driver

Risk/Reward remains attractive as long as $270 holds.

🟢 BUY SETUP🎯 StrategyAggressive entry:
Break and hold above $300 → momentum continuation trade
Preferred entry (smart money approach):
Buy the dip in the $270–280 zone
🛑 Stop-LossBelow $260 (trend invalidation level)
🎯 Targets

• $315 (short-term momentum target)
• $335–350 (swing target if trend continues)

📊 Final ConclusionTrend is clearly bullish.
Valuation is elevated, but sector strength and growth momentum support the premium.
🔔 Rating:BUY on dips toward $270–280
Momentum traders can enter on a confirmed breakout above $300.

Travere Therapeutics (TVTX) 💊
Status: Highlighted in green. TVTX reported excellent results yesterday (Feb 19), delivering a strong earnings beat. Revenue increased by 90% year-over-year, driven by their drug sparsentan.
AI Check: The AI score of 8/10 and the SST-rating of 3.8 confirm that the fundamentals are improving.
Strategy: Despite insider selling in December, analysts remain bullish with price targets around $38. The post-earnings dip appears to be a buying opportunity.